PDF(1030 KB)
PDF(1030 KB)
PDF(1030 KB)
小儿暴发性心肌炎危险因素分析
Risk factors for acute fulminant myocarditis in children
目的：通过对小儿病毒性心肌炎临床表现、体征以及实验室检查指标等方面进行回顾性分析研究，以探讨小儿暴发性心肌炎的危险因素。方法：收集临床诊断为病毒性心肌炎患儿资料71例，分为暴发性心肌炎组(n=16)和非暴发性心肌炎组(n=55)，采用χ2检验或t检验对两组患儿入院时的临床表现、心电图、心脏B超与血清生化检查等各项指标进行回顾性分析，对有统计学意义的相关因素，进行logistic多元回归分析，研究暴发性心肌炎的独立高危因素。结果：暴发性心肌炎组死亡率远高于非暴发性心肌炎组（50% vs 0%）。急性病毒性心肌炎患儿入院时血压降低、血清CK-MB水平升高、cTnI阳性、心电图QRS波时限延长、ST段改变、完全性房室传导阻滞、完全性左束支传导阻滞，以及左室射血分数和左室短轴缩短率降低与心肌炎暴发阶段密切相关。QRS波群时限延长（OR＝1.139;CI＝1.014~1.279; P<0.05）和左心室射血分数降低（OR＝0.711;CI＝0.533~0.949;P<0.05）是小儿暴发性心肌炎的独立阳性预测因素。结论：暴发性心肌炎死亡率高。入院时QRS波群时限延长和左心室射血分数降低是小儿暴发性心肌炎的独立危险因素。［中国当代儿科杂志，2009，11（8）：627-630］
OBJECTIVE: To investigate the risk factors for fulminant myocarditis by analyzing clinical symptoms/signs or laboratory findings in children with viral myocarditis. METHODS: The medical data of 71 children with acute viral myocarditis from March 2005 to September 2008 were retrospectively studied. They were classified into fulminant (n=16) and non-fulminant myocarditis groups (n=55). Chi-square and Student's t-test were used to analyze the clinical presentations, laboratory data, EEG and cardiac ultrasound findings on admission. The multiple regression analysis was used to identify the independent risk factors for fulminant myocarditis. RESULTS: Eight children (50%) died in the fulminant myocarditis group, but none in the non-fulminant group. The following factors were closely related to the fulminant course of myocarditis: lower blood pressure, higher serum CK-MB level, positive cTnI, complete atrioventricular block and left bundle branch block, ST segment alterations, prolonged QRS complex, and decreased left ventricular ejection fraction and short axis fractional shortening. Multiple regression analysis revealed that prolonged QRS complex (OR=1.139; CI=1.014-1.279, P<0.05) and decreased left ventricular ejection fraction (OR= 0.711; CI=0.533-0.949, P<0.05) were independent risk factors for fulminant myocarditis. CONCLUSIONS: The mortality of fulminant myocarditis is high in children. Prolonged QRS complex and decreased left ventricular ejection fraction on admission are independent risk factors for fulminant myocarditisin in children.［Chin J Contemp Pediatr, 2009, 11 (8):627-630］
Fulminant myocarditis / QRS complex / Left ventricular ejection fraction / Child
［1］Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment［J］. Circulation, 2006, 113（6）:876-890.
［2］McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis［J］. N Engl J Med, 2000, 342(10):734-735.
［3］Freedman SB, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J, et al. Pediatric myocarditis:emergency department clinical findings and diagnostic evaluation［J］. Pediatrics, 2007, 120(6):1278-1285.
［4］Aretz HT. Myocarditis. A histopathologic definition and classification［J］. Am J Cardiovasc Pathol, 1987, 1（1）:3-14.
［5］Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology［J］. Circulation, 2007, 116（19）:2216-2233.
［6］中华医学会儿科学分会心血管组，中华儿科杂志编辑委员会. 病毒性心肌炎诊断标准（修订草案）［J］. 中华儿科杂志, 2000, 38（2）：75.
［7］Gupta S, Markham DW, Drazner MH, Mammen PP Medscape. Fulminant myocarditis［J］. Nat Clin Pract Cardiovasc Med, 2008, 5(11):693-706.
［8］马沛然. 肾上腺皮质激素治疗小儿病毒性心肌炎［J］. 世界临床药物, 2003, 24（7）：395-397.
［9］刘神幼，杨波. 病毒性心肌炎的药物治疗进展［J］. 医药导报, 2008，27（3）：308-310.
［10］Robinson JL, Hartling L, Crumley E, Vandermeer B, Klassen TP. A systematic review of intravenous gamma globulin for therapy of acute myocarditis［J］. BMC Cardiovasc Disord, 2005, 5(1):12.
［11］Reiss N, El-Banayosy A, Arusoglu L, Blanz U, Bairaktaris A, Koerfer R. Acute fulminant myocarditis in children and adolescents:the role of mechanical circulatory assist［J］. ASAIO J, 2006, 52(2):211-214.
［12］Lin CH, Chang JS, Li PC. The rescue of acute fulminant myocarditis by extracorporeal membrane oxygenation in pediatric patients［J］. Acta Paediatr Taiwan, 2005, 46(4):201-205.
［13］Chen YS, Yu HY. Choice of mechanical support for fulminant myocarditis: ECMO vs. VAD?［J］.Eur J Cardiothorac Surg, 2005, 27(5):931-932.
［14］Chen YS, Yu HY, Huang SC, Chiu KM, Lin TY, Lai LP, et al. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first?［J］.J Heart Lung Transplant, 2005, 24(1):8187.
［15］Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute fulminant myocarditis in children［J］. Heart, 2006, 92(9):1269-1273.
［16］Canter CE. Therapy for pediatric myocarditis［J］. Curr Treat Options Cardiovasc Med, 2005, 7(5):411-417.
［17］Chang YJ, Chao HC, Hsia SH, Yan DC. Myocarditis presenting as gastritis in children［J］. Pediatr Emerg Care, 2006, 22(6):439-440.
［18］杨英珍. 病毒性心脏病［M］. 上海：上海科学技术出版社, 2000,230-250.
［19］Lee CH, Tsai WC, Hsu CH, Liu PY, Lin LJ, Chen JH. Predictive factors of a fulminant course in acute myocarditis［J］. Int J Cardiol, 2006, 109(1):142-145.
［20］Matitiau A, Perez-Atayde A, Sander SP, Sluysmans T, Parness IA, Spevak PJ, et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation［J］. Circulation, 1994, 90(3):1310-1318.
［21］Kato S, Morimoto SI, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, et al. Risk factors for patients developing a fulminant course with actue myocarditis［J］. Circ J, 2004, 68(8):734-739.
［22］Morgera T, Di Lenarda A, Dreas L, Pinamonti B, Humar F, Bussani R, et al. Electrocardiography of myocarditis revisited: clinical and prognostic signficance of electrocardiograohic changes［J］. Am Heart J, 1992,124(2):455-467.
［23］李格丽,陈国祯,覃有振,李运泉,朱延力.小儿病毒性心肌炎217例临床分析［J］.中山大学学报（医学科学版), 2005, 26(6):183-185.
［24］王锐，师延明，曾平，曾雁云，李红玲.儿童心肌炎心电图监测临床价值探讨［J］.中国当代儿科杂志，2007，9（3）：213-215.
